PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ATAI vs. IOVA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


ATAIIOVA
YTD Return14.18%0.62%
1Y Return45.05%85.91%
3Y Return (Ann)-49.29%-25.40%
Sharpe Ratio0.390.78
Sortino Ratio1.331.81
Omega Ratio1.141.21
Calmar Ratio0.360.74
Martin Ratio0.932.05
Ulcer Index36.70%35.26%
Daily Std Dev88.56%92.09%
Max Drawdown-94.77%-99.37%
Current Drawdown-91.91%-94.86%

Fundamentals


ATAIIOVA
Market Cap$244.99M$2.95B
EPS-$0.36-$1.48
Total Revenue (TTM)$291.00K$90.86M
Gross Profit (TTM)$25.00K-$12.33M
EBITDA (TTM)-$83.01M-$399.47M

Correlation

-0.50.00.51.00.4

The correlation between ATAI and IOVA is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

ATAI vs. IOVA - Performance Comparison

In the year-to-date period, ATAI achieves a 14.18% return, which is significantly higher than IOVA's 0.62% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%20.00%JuneJulyAugustSeptemberOctoberNovember
-5.80%
-20.11%
ATAI
IOVA

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ATAI vs. IOVA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Atai Life Sciences N.V. (ATAI) and Iovance Biotherapeutics, Inc. (IOVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ATAI
Sharpe ratio
The chart of Sharpe ratio for ATAI, currently valued at 0.39, compared to the broader market-4.00-2.000.002.000.39
Sortino ratio
The chart of Sortino ratio for ATAI, currently valued at 1.33, compared to the broader market-4.00-2.000.002.004.001.33
Omega ratio
The chart of Omega ratio for ATAI, currently valued at 1.14, compared to the broader market0.501.001.502.001.14
Calmar ratio
The chart of Calmar ratio for ATAI, currently valued at 0.36, compared to the broader market0.002.004.006.000.36
Martin ratio
The chart of Martin ratio for ATAI, currently valued at 0.93, compared to the broader market0.0010.0020.0030.000.93
IOVA
Sharpe ratio
The chart of Sharpe ratio for IOVA, currently valued at 0.78, compared to the broader market-4.00-2.000.002.000.78
Sortino ratio
The chart of Sortino ratio for IOVA, currently valued at 1.81, compared to the broader market-4.00-2.000.002.004.001.81
Omega ratio
The chart of Omega ratio for IOVA, currently valued at 1.21, compared to the broader market0.501.001.502.001.21
Calmar ratio
The chart of Calmar ratio for IOVA, currently valued at 0.86, compared to the broader market0.002.004.006.000.86
Martin ratio
The chart of Martin ratio for IOVA, currently valued at 2.05, compared to the broader market0.0010.0020.0030.002.05

ATAI vs. IOVA - Sharpe Ratio Comparison

The current ATAI Sharpe Ratio is 0.39, which is lower than the IOVA Sharpe Ratio of 0.78. The chart below compares the historical Sharpe Ratios of ATAI and IOVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
0.39
0.78
ATAI
IOVA

Dividends

ATAI vs. IOVA - Dividend Comparison

Neither ATAI nor IOVA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ATAI vs. IOVA - Drawdown Comparison

The maximum ATAI drawdown since its inception was -94.77%, roughly equal to the maximum IOVA drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for ATAI and IOVA. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%JuneJulyAugustSeptemberOctoberNovember
-91.91%
-70.39%
ATAI
IOVA

Volatility

ATAI vs. IOVA - Volatility Comparison

Atai Life Sciences N.V. (ATAI) has a higher volatility of 33.59% compared to Iovance Biotherapeutics, Inc. (IOVA) at 24.63%. This indicates that ATAI's price experiences larger fluctuations and is considered to be riskier than IOVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%JuneJulyAugustSeptemberOctoberNovember
33.59%
24.63%
ATAI
IOVA

Financials

ATAI vs. IOVA - Financials Comparison

This section allows you to compare key financial metrics between Atai Life Sciences N.V. and Iovance Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items